Chinese court freezes 2.14 billion yuan in Nexperia-affiliated assets amid custody dispute
Quick Look
A Chinese court has frozen 2.14 billion yuan (US$318 million) in assets tied to Nexperia and its spin-off Itec BV across Dongguan, Shanghai, and Wuxi to prevent asset transfers during a custody battle, reinforcing operational separation between the Dutch firm's Chinese manufacturing units and its European headquarters.
AI-generated summary
Why It Matters
Nexperia, a Dutch semiconductor manufacturer, has been involved in a custody battle over its Chinese operations, with Wingtech filing related disclosures to the Shanghai Stock Exchange. Itec BV was spun off from Nexperia in 2021 as a chip tool maker.
A Chinese court’s order to freeze 2.14 billion yuan (US$318 million) in Nexperia-affiliated assets has cemented the operational independence of its Chinese manufacturing engine from its European headquarters, leaving its local facilities increasingly isolated amid a prolonged custody battle.
The Dongguan Intermediate People’s Court in the southern province of Guangdong, where Nexperia’s biggest assembly and test plant is located, has frozen the equity interests in four subsidiaries owned by the Dutch firm, Wingtech said in a Monday filing to the Shanghai Stock Exchange.
Meanwhile, equity interests in another Chinese entity owned by Itec BV, a chip tool maker spun off from Nexperia in 2021, have also been frozen.
The ruling, affecting 2.14 billion yuan worth of combined assets across the cities of Dongguan, Shanghai and Wuxi, is due to last for three years, until August 2029.
The move is designed to “protect Chinese subsidiaries’ assets from being transferred or pledged as collateral”, while their daily operations would not be affected, said Luo Zhiyu, a partner at the DeHeng Law Offices in Beijing who specialises in cross-border transactions and overseas listings.
What to Watch
AI outlook — possibilities, not facts
Nexperia will appeal the asset freeze ruling or seek legal resolution through international arbitration
Possible · Within months
Open Questions
- What is the nature of the custody battle between Nexperia and its Chinese partners?
- Will the asset freeze disrupt supply chains or production at the Dongguan facility?
- Are there ongoing negotiations or legal appeals regarding the frozen assets?
